Skip to main content
Full access
Editorials
Published Online: 1 April 2019

Using Insomnia as a Model for Optimizing Internet-Delivered Psychotherapy

Insomnia is a prevalent and distressing issue, with approximately 30% of the population experiencing at least one symptom of insomnia and 6% of the population meeting criteria for an insomnia disorder (1). Historically, insomnia has been considered a secondary symptom of psychiatric disorders, leading to the unfortunate consequence of psychiatric treatment largely disregarding insomnia as a focus of therapy. However, a more recent large body of prospective studies has demonstrated a bidirectional relationship between insomnia and psychiatric disorders, with evidence supporting insomnia’s contribution to the development of depression, anxiety, alcohol abuse, psychosis, and suicidality (2, 3). Thus, the value of assessing and treating insomnia in the treatment and possible prevention of mental illness has come to the forefront in psychiatry.
Cognitive-behavioral therapy (CBT) for insomnia has a strong evidence base and is recommended as an initial treatment in those with insomnia alone and also those with comorbid insomnia (4). More specifically, a meta-analysis examined the efficacy of CBT for insomnia in those with insomnia comorbid with alcohol dependence, depression, posttraumatic stress disorder, or mixed psychiatric diagnoses (5). Results revealed that CBT for insomnia demonstrated not only medium to large treatment effects on insomnia in these psychiatric patients but also modest treatment effects on their comorbid psychiatric symptoms. Unfortunately, CBT for insomnia is often not easily accessible to patients in need because of factors such as cost and shortage of trained providers (6).
To increase accessibility, recent efforts have been made to develop and test CBT for insomnia in interactive, Internet-based formats. Results have demonstrated similar treatment outcomes for insomnia using these formats as those using in-person CBT for insomnia (7, 8). Moreover, Internet-based formats have allowed for larger-scale prospective randomized studies that examine the effect of insomnia treatment on psychiatric symptoms. For example, Freeman et al. (9) randomly assigned 3,755 U.K. university students who reported significant insomnia symptoms to receive either Internet-based CBT for insomnia or treatment as usual and examined how treatment affected a variety of mental health symptoms. Results revealed that those receiving Internet-based CBT for insomnia not only had significantly less insomnia but also reduced paranoia, hallucinations, depressive symptoms, and anxiety symptoms. These findings are of great importance considering the positive impact a more easily accessed intervention had on both insomnia and psychiatric symptoms. At the same time, the dropout rate of this study (50%), which is similar to that of other Internet-based CBT for insomnia studies, must be considered as a limitation and addressed to optimize care delivery.
Consistent with stepped-care models for the delivery of insomnia treatment (10), the most efficient use of limited resources comes from matching interventions to patient needs and making the best use of available expertise. In the case of Internet-based CBT for insomnia, early identification of potential treatment failures that can be addressed to alter treatment trajectory is key to making this model of care truly scalable. In this issue of the Journal, Forsell and colleagues (11) provide a promising approach to reverse potential treatment failure with Internet-based CBT for insomnia. In this study, 251 participants with insomnia disorder participated in a 9-week Internet-based CBT for insomnia program. During the third week of treatment, using a semi-automated algorithm based on questionnaire measures and engagement in the program, 102 participants were classified as at risk of experiencing treatment failure (Red group), and 149 were classified as not at risk of experiencing treatment failure (Green group). Using a single-blind design, those at risk were then randomly assigned to an adapted treatment (Red-Adapted; N=51) or to continue with regular treatment (Red-Standard; N=51). Results demonstrated that treatment failure could be predicted, in that patients in the Green group had significantly greater reductions in insomnia severity over the course of treatment than those in the Red-Standard group. Treatment adaptation also was efficacious in that the Red-Adapted group reported significantly greater reduction in insomnia severity than the Red-Standard group after randomization. In terms of clinical significance, treatment failure was significantly more likely in the Red-Standard group (64%) than in the Green and Red-Adapted groups (23% and 37%, respectively).
This study has many strengths, including a well-defined sample of individuals with insomnia disorder, the choice of primary and secondary outcome variables that follow current insomnia assessment recommendations, and a low attrition rate. Furthermore, the adapted treatment involved a minimal increase of therapist time per patient (i.e., about 14 minutes weekly), and adaptation examples provided in the online supplement of the article offer reasonable suggestions that remain adherent to a CBT for insomnia model and address common issues in clinical practice with insomnia intervention.
Although the study was well designed, the broad applicability and generalizability of these findings will need to be refined through future lines of inquiry. The authors’ selection of variables for the at-risk classification algorithm has a strong empirical basis, and it demonstrated utility in identifying potential treatment failures in their study. However, the applicability of this algorithm to in-person CBT for insomnia and other Internet-based platforms is not clear. Additionally, the present study does not provide long-term follow-up data and excluded those with an active psychiatric comorbidity. More research providing long-term follow-up with adapted treatment for those with and without comorbid insomnia is needed.
In summary, Forsell and colleagues offer an innovative psychotherapy adaptation strategy in the context of insomnia treatment, demonstrating an ability to identify potential therapeutic failures in Internet-delivered care, with subsequent adjustment to treatment to achieve improved outcomes. Further key research directions include continuing to develop effective and feasible algorithms to identify potential treatment failures with both Internet-based and in-person treatment formats, and improving short- and long-term outcomes for a variety of populations. Translating these findings into clinical practice also will require that these lines of inquiry be advanced with an appreciation for evolving and complex access limitations (insurance, financial, regulatory, etc.) to Internet-based psychotherapy programs for insomnia. These future directions and considerations apply not only to advancing innovative psychotherapy practices for insomnia but also Internet-delivered psychotherapy for mental illness more broadly.

References

1.
Ohayon MM: Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6:97–111
2.
Hertenstein E, Feige B, Gmeiner T, et al: Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep Med Rev 2019; 43:96–105
3.
Rössler W, Angst J, Ajdacic-Gross V, et al: Sleep disturbances and suicidality: a longitudinal analysis from a representative community study over 30 years. Front Psychiatry 2018; 9:320
4.
Schutte-Rodin S, Broch L, Buysse D, et al: Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008; 4:487–504
5.
Wu JQ, Appleman ER, Salazar RD, et al: Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med 2015; 175:1461–1472
6.
Thomas A, Grandner M, Nowakowski S, et al: Where are the behavioral sleep medicine providers and where are they needed? A geographic assessment. Behav Sleep Med 2016; 14:687–698
7.
Espie CA, Fleming L, Cassidy J, et al: Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 2008; 26:4651–4658
8.
Ritterband LM, Thorndike FP, Ingersoll KS, et al: Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial. JAMA Psychiatry 2017; 74:68–75
9.
Freeman D, Sheaves B, Goodwin GM, et al: The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. Lancet Psychiatry 2017; 4:749–758
10.
Espie CA: “Stepped care”: a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 2009; 32:1549–1558
11.
Forsell E, Jernelöv S, Blom K, et al: Proof of concept for an adaptive treatment strategy to prevent failures in Internet-delivered CBT: a single-blind randomized clinical trial with insomnia patients. Am J Psychiatry 2019; 176:315–323

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 267 - 268
PubMed: 30929498

History

Accepted: 5 February 2019
Published online: 1 April 2019
Published in print: April 01, 2019

Keywords

  1. Psychotherapy
  2. Administration
  3. Sleep
  4. Behavior Therapy
  5. Computers

Authors

Details

Meredith E. Rumble, Ph.D. [email protected]
Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison.
David T. Plante, M.D., Ph.D.
Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison.

Notes

Send correspondence to Dr. Rumble ([email protected]).

Funding Information

Dr. Rumble receives grant support from Merck and has received grant support from NIH. Dr. Plante has received research support from the American Sleep Medicine Foundation, the Brain and Behavior Research Foundation, the Madison Education Partnership, NIMH, and the University of Illinois at Chicago Occupational and Environmental Health and Safety Education and Research Center (funded by the National Institute for Occupational Safety and Health). Dr. Plante has also served as a consultant for Jazz Pharmaceuticals and Teva Australia. Dr. Kalin has reviewed this editorial and found no evidence of influence from these relationships.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share